MARKSANS Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Marksans Pharma Ltd

Watchlist Manager

Watchlist

Price: 329.4 INR -0.3% Market Closed

Market Cap: ₹149.3B

	Marksans Pharma Ltd NSE:MARKSANS	IN
K	Kyocera Corp F:KYR	JP
B	BCE Inc F:BCE1	CA
K	Kinross Gold Corp SWB:KIN2	CA
A	Ansell Ltd OTC:ANSLY	AU
T	Tractor Supply Co F:TR4	US
B	Ball Corp F:BL8	US
	Vinci SA PAR:DG	FR

Profitability Summary

Marksans Pharma Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

57%

Strong 3Y Average Gross Margin

54%

Gross Margin is Increasing

51% > 57%

Healthy Operating Margin

19%

Sustainable 3Y Average Operating Margin

17%

Operating Margin is Increasing

16% > 19%

Healthy Net Margin

16%

Sustainable 3Y Average Net Margin

14%

Net Margin is Increasing

14% > 16%

Exceptional Free Cash Flow Margin

10%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

10% > 10%

Positive ROE

19%

Positive 3Y Average ROE

Positive 3Y Average ROIC

18%

Declining ROIC

21% > 19%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.